FDA

FDA Approves Third Dose Of Pfizer Against COVID-19 In Seniors And At Risk

La FDA aprobó de manera oficial la tercera dosis contra el COVID-19 en personas mayores de 65 años y población en riesgo.

The FDA officially approved the third dose against COVID-19 in people over 65 years of age and population at risk. Photo: Robyn Beck / Getty Images The Food and Drug Administration (FDA) officially approved this Wednesday the third dose of the Pfizer-BionTech vaccine for Americans 65 and older and at-risk seniors. Despite an additional injection …

FDA Approves Third Dose Of Pfizer Against COVID-19 In Seniors And At Risk Read More »

US Government Authorizes Pfizer Vaccine to Prevent COVID-19

El Gobierno de EE.UU. autoriza la vacuna de Pfizer para prevenir el COVID-19

The United States Government reported on Friday night that it has authorized the use of the vaccine for COVID-19 prevention in 16-year-olds of age or older. The US Food and Drug Administration (FDA) said in a statement that the emergency authorization from the firm Pfizer-BioNTech will allow distribution of the vaccine in the country. A …

US Government Authorizes Pfizer Vaccine to Prevent COVID-19 Read More »